- Home
- KALV vs PTLO Comparison
KALV vs PTLO Comparison
Compare KALV & PTLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- PTLO
- Stock Information
- Founded
- KALV N/A
- PTLO 1963
- Country
- KALV United States
- PTLO United States
- Employees
- KALV N/A
- PTLO N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- PTLO Restaurants
- Sector
- KALV Health Care
- PTLO Consumer Discretionary
- Exchange
- KALV Nasdaq
- PTLO Nasdaq
- Market Cap
- KALV 637.9M
- PTLO 548.6M
- IPO Year
- KALV N/A
- PTLO 2021
- Fundamental
- Price
- KALV $15.82
- PTLO $6.82
- Analyst Decision
- KALV Strong Buy
- PTLO Buy
- Analyst Count
- KALV 9
- PTLO 8
- Target Price
- KALV $26.29
- PTLO $13.00
- AVG Volume (30 Days)
- KALV 734.1K
- PTLO 3.5M
- Earning Date
- KALV 09-09-2025
- PTLO 11-04-2025
- Dividend Yield
- KALV N/A
- PTLO N/A
- EPS Growth
- KALV N/A
- PTLO 17.90
- EPS
- KALV N/A
- PTLO 0.46
- Revenue
- KALV N/A
- PTLO $727,754,000.00
- Revenue This Year
- KALV N/A
- PTLO $7.95
- Revenue Next Year
- KALV $221.95
- PTLO $12.38
- P/E Ratio
- KALV N/A
- PTLO $14.96
- Revenue Growth
- KALV N/A
- PTLO 3.62
- 52 Week Low
- KALV $7.30
- PTLO $6.67
- 52 Week High
- KALV $16.32
- PTLO $15.78
- Technical
- Relative Strength Index (RSI)
- KALV 71.16
- PTLO 28.36
- Support Level
- KALV $13.72
- PTLO $6.67
- Resistance Level
- KALV $13.96
- PTLO $7.12
- Average True Range (ATR)
- KALV 0.69
- PTLO 0.22
- MACD
- KALV 0.31
- PTLO 0.08
- Stochastic Oscillator
- KALV 99.15
- PTLO 14.22
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.